Lidokainklorid Galenika

Lidocaine Hydrochloride, the active ingredient in Lidokainklorid, is a local anesthetic presented as a sterile solution for epidural, infiltration, and intradermal use. It provides reversible loss of sensation in targeted tissues for minor surgical procedures and pain‑management interventions. GNH USA supplies Lidokainklorid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidokainklorid is a local anesthetic used in procedures that require regional nerve blockade. - Minor surgical procedures: provides local anesthesia to reduce pain during the operation. - Epidural analgesia: delivers regional pain relief during labor or surgical procedures. - Infiltration anesthesia: numbs targeted tissue for diagnostic or therapeutic interventions. - Intradermal testing: used as a reagent for skin allergy testing.

Lidokainklorid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Transient burning or stinging at the injection site - Mild dizziness or light‑headedness - Nausea or metallic taste - Localized swelling or erythema

Serious or Rare Side Effects: - Allergic reactions such as rash, angioedema, or anaphylaxis - Cardiac arrhythmias, including ventricular tachycardia - Central nervous system toxicity (seizures, loss of consciousness) - Methemoglobinemia, a rare blood disorder affecting oxygen transport

Before using Lidokainklorid, consider the following safety measures. - Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Cardiovascular status: avoid in patients with severe heart block or conduction disorders. - Dosage limits: adhere to recommended maximum dose to prevent systemic toxicity. - Concurrent CNS depressants: monitor for enhanced sedation when combined with other depressants. - Pregnancy and lactation: use only if the benefit outweighs the potential risk (category unknown). - Store at room temperature: keep in the original container, protect from moisture and light.

Lidokainklorid can interact with other medicines, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase lidocaine plasma levels. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise systemic exposure. - Concurrent use of other local anesthetics: additive risk of toxicity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may potentiate cardiac effects of lidocaine. - Diuretics such as furosemide: may reduce plasma protein binding, increasing free drug. - General anesthetics (e.g., propofol): may enhance central nervous system depression.